Published in Am J Geriatr Psychiatry on July 01, 2008
Can persons with dementia be engaged with stimuli? Am J Geriatr Psychiatry (2010) 1.10
Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies? Curr Alzheimer Res (2016) 0.75
Non-pharmacological Management of Behavioral Symptoms in Frontotemporal and Other Dementias. Curr Neurol Neurosci Rep (2016) 0.75
Global prevalence of dementia: a Delphi consensus study. Lancet (2005) 23.30
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med (2006) 10.89
Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA (2005) 6.20
Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. JAMA (2003) 5.23
Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis. Neurobiol Aging (2001) 4.32
Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry (2000) 4.23
Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry (2006) 3.83
Translational research: moving discovery to practice. Clin Pharmacol Ther (2007) 3.78
Tailored activities to manage neuropsychiatric behaviors in persons with dementia and reduce caregiver burden: a randomized pilot study. Am J Geriatr Psychiatry (2008) 2.38
The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database Syst Rev (2006) 2.14
Treatment of agitation in AD: a randomized, placebo-controlled clinical trial. Neurology (2000) 2.10
ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology (2007) 2.09
Nonpharmacological treatment of agitation: a controlled trial of systematic individualized intervention. J Gerontol A Biol Sci Med Sci (2007) 1.60
Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis. Int J Geriatr Psychiatry (2008) 1.51
Persistence of and changes in neuropsychiatric symptoms in Alzheimer disease over 6 months: the LASER-AD study. Am J Geriatr Psychiatry (2005) 1.51
Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment. Neurology (2006) 1.47
Atypical antipsychotics and glucose dysregulation: a systematic review. Schizophr Res (2004) 1.44
Neuroanatomical characteristics of geriatric apathy and depression: a magnetic resonance imaging study. Am J Geriatr Psychiatry (2007) 1.29
Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial. Am J Geriatr Psychiatry (2005) 1.27
Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J Am Geriatr Soc (1999) 1.25
Clinically significant non-major depression: old concepts, new insights. Am J Geriatr Psychiatry (2002) 1.18
The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes--a 12-month follow-up study. Am J Geriatr Psychiatry (2008) 1.16
Determinants of the quality of life in Alzheimer's disease patients as assessed by the Japanese version of the Quality of Life-Alzheimer's disease scale. Dement Geriatr Cogn Disord (2006) 1.09
Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders. Am J Geriatr Psychiatry (2006) 1.07
Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality. J Clin Psychiatry (2000) 1.04
A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease. Am J Geriatr Psychiatry (2008) 0.93
Apathy associated with Alzheimer disease: use of dextroamphetamine challenge. Am J Geriatr Psychiatry (2008) 0.89
Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies. J Clin Psychiatry (2006) 0.88
Apathy and its treatment. Curr Treat Options Neurol (2007) 0.87
An individualized psychosocial approach for "treatment resistant" behavioral symptoms of dementia among aged care residents. Int Psychogeriatr (2006) 0.85
Valproic acid for agitation in dementia. Cochrane Database Syst Rev (2004) 0.81
Nonpharmacological treatment of inappropriate sexual behavior in dementia: the case of the pink panther. Am J Geriatr Psychiatry (2008) 0.81
Comorbidity of psychopathological domains in community-dwelling persons with Alzheimer's disease. J Geriatr Psychiatry Neurol (2003) 0.80
Pharmacotherapy of neuropsychiatric syndromes in neurologic disorders: definitional and regulatory aspects. Psychopharmacol Bull (2007) 0.79
Does behavioral improvement with haloperidol or trazodone treatment depend on psychosis or mood symptoms in patients with dementia? J Am Geriatr Soc (2001) 0.79
Divalproex sodium for the treatment of behavioural problems associated with dementia in the elderly. Drugs Aging (2006) 0.78
Epidemiology and management of apathy in patients with Alzheimer's disease. Drugs Aging (2007) 0.78
Agitation and psychosis in dementia. Am J Geriatr Psychiatry (2007) 0.78
Therapy of depression in dementia. Expert Rev Neurother (2003) 0.77
PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med (2006) 6.02
Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. Am J Psychiatry (2004) 3.84
Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex. Am J Psychiatry (2004) 2.24
Effects of a 14-day healthy longevity lifestyle program on cognition and brain function. Am J Geriatr Psychiatry (2006) 1.93
A tune in "a minor" can "b major": a review of epidemiology, illness course, and public health implications of subthreshold depression in older adults. J Affect Disord (2011) 1.75
Yogic meditation reverses NF-κB and IRF-related transcriptome dynamics in leukocytes of family dementia caregivers in a randomized controlled trial. Psychoneuroendocrinology (2012) 1.63
Differential FDDNP PET patterns in nondemented middle-aged and older adults. Am J Geriatr Psychiatry (2009) 1.62
Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia. Arch Gen Psychiatry (2009) 1.44
Sleep disturbance and depression recurrence in community-dwelling older adults: a prospective study. Am J Psychiatry (2008) 1.38
Mapping brain size and cortical gray matter changes in elderly depression. Biol Psychiatry (2004) 1.12
Localizing gray matter deficits in late-onset depression using computational cortical pattern matching methods. Am J Psychiatry (2004) 1.09
Cognitive behavioral therapy vs. Tai Chi for late life insomnia and inflammatory risk: a randomized controlled comparative efficacy trial. Sleep (2014) 1.07
Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy. Am J Psychiatry (2002) 1.05
Estrogen use and brain metabolic change in postmenopausal women. Neurobiol Aging (2005) 1.04
Executive dysfunction and memory in older patients with major and minor depression. Arch Clin Neuropsychol (2007) 0.99
Executive dysfunction and memory in older patients with major and minor depression. Arch Clin Neuropsychol (2006) 0.98
Prediction of cognitive decline by positron emission tomography of brain amyloid and tau. Arch Neurol (2012) 0.94
Influences of lobar gray matter and white matter lesion load on cognition and mood. Psychiatry Res (2010) 0.89
Daily functioning and prefrontal brain morphology in healthy and depressed community-dwelling elderly. Am J Geriatr Psychiatry (2008) 0.88
Executive dysfunction and visuospatial ability among depressed elders in a community setting. Arch Clin Neuropsychol (2004) 0.87
Tai Chi and Qigong for the treatment and prevention of mental disorders. Psychiatr Clin North Am (2013) 0.87
MRI subcortical hyperintensities in old and very old depressed outpatients: the important role of age in late-life depression. J Neurol Sci (2002) 0.87
Prior depression history and deterioration of physical health in community-dwelling older adults--a prospective cohort study. Am J Geriatr Psychiatry (2010) 0.84
Self-reported memory impairment and brain PET of amyloid and tau in middle-aged and older adults without dementia. Int Psychogeriatr (2012) 0.84
Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study. Am J Geriatr Psychiatry (2008) 0.82
Stress, inflammation, and aging. Am J Geriatr Psychiatry (2012) 0.81
A pilot study of the effects of meditation on regional brain metabolism in distressed dementia caregivers. Aging health (2012) 0.79
Rapid response of major depressive disorder and comorbid eating disorder NOS to a novel meditation intervention. Psychosomatics (2012) 0.78
Vascular risk and FDDNP-PET influence cognitive performance. J Alzheimers Dis (2013) 0.77
Natural products and supplements for geriatric depression and cognitive disorders: an evaluation of the research. Curr Psychiatry Rep (2014) 0.77
Vascular burden and cognitive functioning in depressed older adults. Am J Geriatr Psychiatry (2012) 0.77
Feasibility of central meditation and imagery therapy for dementia caregivers. Int J Geriatr Psychiatry (2014) 0.76
The aging brain: current concepts, intervention strategies and the role of Ginkgo biloba extract EGb 761. Introduction. Int Psychogeriatr (2012) 0.75